Extracorporeal membrane oxygenation for adult cardiac support: the allegheny experience George J Magovern, MD, Kathleen A Simpson, BS The Annals of Thoracic Surgery Volume 68, Issue 2, Pages 655-661 (August 1999) DOI: 10.1016/S0003-4975(99)00581-0
Fig 1 Comparison of mean BioPump flow (L/min) in PCCS patients who died during hospitalization (nonsurvivors) and patients who survived to hospital discharge (survivors). A 40-hour review is illustrated; mean and median length of assist in this population is approximately 42 hours. The Annals of Thoracic Surgery 1999 68, 655-661DOI: (10.1016/S0003-4975(99)00581-0)
Fig 2 Comparison of mean BioPump flow (L/min) in PCCS patients cannulated by the femoral venoarterial route and the transthoracic right atrial to aortic route. A 40-hour review is illustrated; mean and median length of assist in this population is approximately 42 hours. The Annals of Thoracic Surgery 1999 68, 655-661DOI: (10.1016/S0003-4975(99)00581-0)
Fig 3 Mean platelet counts and pump speed (rpm) recorded at 4-hour intervals during the initial 48 hours of PCCS ECMO support. The Annals of Thoracic Surgery 1999 68, 655-661DOI: (10.1016/S0003-4975(99)00581-0)